Ryan Govender
Chief Executive Officer bei TREATT PLC
Vermögen: 719 $ am 31.03.2024
Aktive Positionen von Ryan Govender
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TREATT PLC | Director/Board Member | 01.07.2022 | - |
| Chief Executive Officer | 01.01.2024 | - | |
| Corporate Secretary | - | - | |
| Director of Finance/CFO | 01.07.2022 | 01.01.2024 | |
| Corporate Officer/Principal | 23.05.2022 | 01.07.2022 |
Karriereverlauf von Ryan Govender
Ehemalige bekannte Positionen von Ryan Govender
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SPI Pharma, Inc.
 SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Director of Finance/CFO | - | - |
Statistik
International
| Vereinigtes Königreich | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Director of Finance/CFO | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Process Industries | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TREATT PLC | Process Industries |
| Private Unternehmen | 1 |
|---|---|
SPI Pharma, Inc.
SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Health Technology |
- Börse
- Insiders
- Ryan Govender
- Erfahrung
